Navigation Links
OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
Date:12/15/2008

New Company Founded on Mayo Clinic Discoveries is Developing Therapies for Wounds, Diabetic Foot Ulcers and Hair Growth Using Nano-Materials with Angiogenic Properties

GILROY, Calif., Dec. 15 /PRNewswire/ -- OmegaGenesis today unveiled the company's novel technology platform which employs nano-materials made of rare earth elements with angiogenic properties. Nanorod therapies for wound healing, diabetic foot ulcers and hair growth are being developed by the company, with plans to expand into the therapeutic areas of ischemic heart damage and orthopedics in the future.

OmegaGenesis has developed novel methods to safely generate large-scale quantities of the nano-scale europium hydroxide rods, which were first developed at the Mayo Clinic and shown to promote angiogenesis, the formation of new blood vessels. The company has established non-toxicity of the europium hydroxide nanorods in lab testing for human applications and pre-clinical studies for use of the nanorods in the treatment of wound healing, diabetic foot ulcers and hair growth are underway. Clinical trials are anticipated to commence in the second half of 2009.

"The angiogenic properties of the europium hydroxide nanorods open up a diverse set of biomedical applications and treatment classes that OmegaGenesis is pursuing," said Oostur Raza, CEO and co-founder. "We are excited to be using nano-scale materials for applications in medicine as it offers a number of advantages over conventional therapies. Nano-materials will enable doctors to treat disease at a sub-cellular level in a less invasive manner than treating disease at the organ or systemic level."

While OmegaGenesis is initially focusing its efforts on developing therapies based on angiogenesis, the company plans to eventually pursue applications in diagnostics and medical imaging, as well as anti-angiogenic therapies for inhibition of tumor growth in cancer.<
'/>"/>

SOURCE OmegaGenesis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
2. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
3. Oregon Tourism Commission Unveils New Online Customer Service Training Program
4. Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
5. Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients
6. Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders
7. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
8. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
9. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
10. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
11. CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014 Yesterday, former Congressman ... device manufacturing facility. Rep. Kennedy and Dick ... facilitate cutting-edge research in neurological disease and treatment. ... health advocate, Garen Staglin , created One ... fundamental changes that will radically accelerate the development ...
(Date:7/10/2014)...   LabStyle Innovations Corp . (OTCQB:DRIO), developer of ... appointment of Professor Richard B. Stone ... Directors. Prof. Stone brings over forty-five ... as an entrepreneur, venture capitalist public, company officer ... He currently serves on the board of directors ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3
... Control, Inc. (Nasdaq: SPEC ), a leading designer ... that it will release its fourth quarter and fiscal year ... of the market. Following the release, Spectrum Control will host ... the Company,s operating results for the quarter and fiscal year ...
... Animal Health today announced an agreement to acquire ... a privately held, Kansas City-based leader in the ... companion and food production animals.   ... using antigen-antibody reaction to detect viruses or bacteria ...
Cached Medicine Technology:Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector 2Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector 3Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector 4
(Date:7/14/2014)... (PRWEB) July 14, 2014 Sometimes, thinking ... company Passionate Playground announces its first product release, Joyboxx™ ... product storage system. , Inventor and CEO, ... consumers to have a storage solution for their ‘toys’ ... multibillion dollar adult retail industry. , Semer met 30-year ...
(Date:7/14/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on Hospira Lactated Ringer’s ... on July 11, that one lot of Lactated Ringers ... by Hospira Inc., is recalled due to mold contamination. ... extracellular losses of fluid and electrolytes, with or without ...
(Date:7/14/2014)... According to the Boost Your Bust book review recently ... want to learn how to increase the size of their breasts ... chapters including:, , Chapter 1 – What Are ... 2 – How Natural Breast Enlargement Works , Chapter ... Chapter 4 – The Groundwork , Chapter ...
(Date:7/14/2014)... Reha Technology today announced the ... and full-featured upper extremity robotic trainer that offers ... games and challenges in a lightweight and economic ... Armotion combines a variety of complex ... the therapy effect for patients with severe and ...
(Date:7/14/2014)... TherapySites, the leading ... professionals, announced today its affiliation with the ... This new relationship allows TherapySites to continue ... members, adding exclusive benefits and promotional offers. , ... dedicated to providing online marketing solutions specifically for ...
Breaking Medicine News(10 mins):Health News:Passionate Playground launches Joyboxx 2Health News:Passionate Playground launches Joyboxx 3Health News:Hospira Lactated Ringer’s and 5% Dextrose Injection Recalled: AttorneyOne Monitor and Keep Consumers Informed 2Health News:Hospira Lactated Ringer’s and 5% Dextrose Injection Recalled: AttorneyOne Monitor and Keep Consumers Informed 3Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 2Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 3Health News:Reha Technology Launches the Armotion™, a Device for the Rehabilitation of the Upper Extremity 2Health News:TherapySites Partners With the Licensed Professional Counselors Association of North Carolina to Make Online Marketing Available to All Therapists 2
... University School of Medicine (BUSM) have quantified the probability ... of the Huntington,s Disease (HD) gene having a child ... very rare event, the probability has never been estimated ... appear on-line in the American Journal of Medical ...
... For matters of health, where you get your information matters ... living is just one click away. , , SCOTTS ... Institute of Alternative Health Care announces today the first nationally ... www.althealthconnect.com ). , , The Alternative Health Connection was ...
... and SCA Personal Care North America , Through its TENA(R) ... National Online, Offline and Grassroots Education Initiatives , , ... the United States are affected by urinary incontinence(1), research shows they,re ... women to talk about their health(2), and when it comes to ...
... June 2009 - Researchers have been seeking a ... associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate ... contribute to the underlying neurobiology of this disorder. ... NMDA receptors administered large amounts of substances, like ...
... Pharmaceutical Inc. (Nasdaq: BMRN ) today announced ... (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of ... Phase 2 clinical study in late June or early ... clinical trial sites. The U.S. Food and Drug ...
... 9 Bruce Matter has joined healthcare IT software ... company growth and client satisfaction. Peminic, with offices in ... management solutions to over 400 acute care and other ... and legal matters. , , Teaming with hospitals, ...
Cached Medicine News:Health News:Researchers estimate risk of transmission of Huntington's disease to offspring among male carriers 2Health News:NIAHC Premiers It's Natural Health Care and Balanced Living Website 2Health News:Bringing Incontinence Out of the Bathroom and Into the Spotlight 2Health News:Bringing Incontinence Out of the Bathroom and Into the Spotlight 3Health News:Bringing Incontinence Out of the Bathroom and Into the Spotlight 4Health News:Bringing Incontinence Out of the Bathroom and Into the Spotlight 5Health News:Animal model for schizophrenia identifies a novel approach for treating cognitive impairments 2Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 2Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 3Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 4Health News:Industry Recognized and Trusted Leader, Bruce Matter, Joins Healthcare IT Company, Peminic, Inc. as Company Growth in the Areas of Patient Safety, Risk Management, and Patient Satisfaction Accelerates 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: